Growth Metrics

Incyte (INCY) Operating Income Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.69%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -347.04%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 80.62%
7 Evaxion A 64.16 Bn 64.14 Bn - 1.27%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,386.07%
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn 46.77%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 46.77%
Dec 31, 2025 11.39%
Sep 30, 2025 203.60%
Jun 30, 2025 210.91%
Mar 31, 2025 123.26%
Dec 31, 2024 61.00%
Sep 30, 2024 -31.96%
Jun 30, 2024 -346.74%
Mar 31, 2024 271.01%
Dec 31, 2023 167.17%
Sep 30, 2023 55.16%
Jun 30, 2023 -23.84%
Mar 31, 2023 -78.75%
Dec 31, 2022 -36.70%
Sep 30, 2022 -41.22%
Jun 30, 2022 80.66%
Mar 31, 2022 17.96%
Dec 31, 2021 -32.57%
Sep 30, 2021 4,320.02%
Jun 30, 2021 -38.97%
Mar 31, 2021 114.88%
Dec 31, 2020 72.86%
Sep 30, 2020 -96.03%
Jun 30, 2020 134.02%
Mar 31, 2020 -996.45%
Dec 31, 2019 512.63%
Sep 30, 2019 331.62%
Jun 30, 2019 18.47%
Mar 31, 2019 210.37%
Dec 31, 2018 -1,481.22%
Sep 30, 2018 107.20%
Jun 30, 2018 1,046.70%
Mar 31, 2018 49.63%
Dec 31, 2017 102.55%
Sep 30, 2017 -32.63%
Jun 30, 2017 -83.72%
Mar 31, 2017 -469.73%
Dec 31, 2016 -482.66%
Sep 30, 2016 22,171.29%
Jun 30, 2016 703.04%
Mar 31, 2016 619.67%
Dec 31, 2015 166.63%
Sep 30, 2015 -100.14%
Jun 30, 2015 71.76%
Mar 31, 2015 69.76%
Dec 31, 2014 11.75%
Sep 30, 2014 630.55%
Jun 30, 2014 -251.20%
Mar 31, 2014 -459.80%
Dec 31, 2013 -312.64%
Sep 30, 2013 -30.04%
Jun 30, 2013 13.80%
Mar 31, 2013 88.02%
Dec 31, 2012 130.94%
Sep 30, 2012 75.92%
Jun 30, 2012 137.02%
Mar 31, 2012 -116.04%
Dec 31, 2011 -357.88%
Sep 30, 2011 -90.90%
Jun 30, 2011 -401.78%
Mar 31, 2011 20.20%